Phase 1 Study of NTB-928 in R/R OC
1d agoen
From the article
Conditions : Relapsed/Refractory Ovarian Carcinoma Interventions : Drug: NTB-928 Sponsors : TeneoSeven, Inc. Recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Una nueva terapia logra atacar el cáncer de ovario reduciendo el daño a las células sanas
Infobae·2d ago
Experimental Novartis radiopharma drug shows promise in early study
reuters.com·1mo ago
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
doi.org·6d ago
CRIS Contra el Cáncer financia una nueva estrategia de terapias dirigidas frente al cáncer de ovario
Infobae·2d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.